Results 21 to 30 of about 37,917 (298)

Advances in Intensified Antithrombotic Therapies in Acute Coronary Syndrome [PDF]

Zhongguo quanke yixue, 2023
Acute coronary syndrome (ACS) is a serious coronary heart disease with relatively high mortality, and a history of ACS is associated with subsequent risk of recurrent ischemic events such as ischemic stroke and myocardial infarction. Platelet aggregation
DENG Tianhua, HUANG Lin, YOU Zhigang
doaj   +1 more source

Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy

Frontiers in Cardiovascular Medicine, 2021
Background: Patients using dual antiplatelet therapy after percutaneous coronary intervention are at risk for bleeding. It is currently unknown whether thrombin generation can be used to identify patients receiving dual antiplatelet therapy with ...
C. P. D. M. de Breet, C. P. D. M. de Breet, S. Zwaveling, S. Zwaveling, M. J. A. Vries, R. G. van Oerle, Y. M. C. Henskens, A. W. J. van't Hof, A. W. J. van't Hof, P. E. J. van der Meijden, L. Veenstra, H. ten Cate, H. ten Cate, R. H. Olie, R. H. Olie   +14 more
doaj   +1 more source

The Risk of Perioperative Bleeding in Patients with Dual Antiplatelet Therapy

Український журнал серцево-судинної хірургії, 2021
Background. Patients with dual antiplatelet therapy have high risk of perioperative bleeding. In this article we evaluated the risk of bleeding in patients whose antiplatelet therapy had not been canceled before coronary artery bypass grafting (CABG).
Taras M. Domanskyy, Artur V. Gabriyelyan, Oleg V. Beregovoy, Stanislav I. Filianin, Svitlana S. Moshta   +4 more
doaj   +1 more source

Gastrointestinal Complications of Dual Antiplatelet Therapy [PDF]

Circulation, 2006
Case presentation: A 59-year-old man with a history of hypertension, dyslipidemia, and smoking was hospitalized with acute coronary syndrome requiring emergency percutaneous coronary intervention with 4 drug-eluting stents. His discharge medications included dual antiplatelet therapy with aspirin 325 mg/d and clopidogrel 75 mg/d.
Neelima G, Vallurupalli, Samuel Z, Goldhaber   +1 more
openaire   +2 more sources

Analysis of Platelet Function from Thromboelastography Examination in Patients with Single and Multiple Antiplatelet Therapy after Percutaneous Coronary Intervention at Dr. Saiful Anwar Malang

Research Journal of Life Science, 2020
Each year, approximately 3 million people with coronary heart disease worldwide undergo percutaneous coronary intervention (PCI). Dual antiplatelet therapy (DAPT) with aspirin and P2Y12 inhibitors became the primary therapy for 6-12 months after PCI ...
Sasmojo Widito, Dadang Hendrawan, Dedy Irawan   +2 more
doaj   +1 more source

Timing of dual antiplatelet therapy in acute coronary syndrome: a problem of coronary artery bypass grafting accessibility for patients

Российский кардиологический журнал, 2020
The feasibility of dual antiplatelet therapy as early as possible in patients with ST-segment elevation acute coronary syndrome, where percutaneous coronary intervention is recommended, has been proven: it improves treatment outcomes by reducing the risk
T. S. Golovina, Yu. N. Neverova, R. S. Tarasov   +2 more
doaj   +1 more source

Hemostasiological Aspects of PCI: Periprocedural Changes in the Activity of the Platelet Link of Hemocoagulation on the Background of Prior Double Antiplatelet Therapy in Patients with Chronic Coronary Syndrome

Український журнал серцево-судинної хірургії, 2023
The aim. To analyze changes in the activity of the platelet link of hemocoagulation in patients with chronic coronary syndrome before and after percutaneous coronary intervention (PCI) against the background of prior antiplatelet therapy.
Nataliia I. Kozachyshyn, Vasyl Z. Netiazhenko, Sergii V. Salo   +2 more
doaj   +1 more source

Dual Antiplatelet Therapy

, 2022
Antiplatelet agents have been utilized to enhance outcomes in patients with acute coronary syndrome for decades and are increasingly valued for their antithrombotic as well as anti-inflammatory characteristics. Dual antiplatelet therapy (DAPT) is a combination of aspirin and a P2Y12 inhibitor.
Edidiong Orok, Funmilayo Adeniyi, Oluwole Akawa   +2 more
openaire   +1 more source

Clinical presentations, antiplatelet strategies and prognosis of patients with stent thrombosis: an observational study of 140 patients. [PDF]

PLoS ONE, 2012
BACKGROUND: Until now there has been scarce evidence regarding an optimal antiplatelet strategy and clinical outcomes for patients who had suffered from stent thrombosis (ST).
Ya-Ling Han, Quan-Yu Zhang, Yi Li, Shao-Yi Guan, Quan-Min Jing, Zu-Lu Wang, Xin Zhao, Xiao-Zeng Wang, Ying-Yan Ma, Bin Wang, Jie Deng, Geng Wang, Young-Hak Kim   +12 more
doaj   +1 more source

Analysis of Dual Antiplatelet Therapy

Journal of the American College of Cardiology, 2015
In a post-hoc analysis, Yeh et al. [(1)][1] provide evidence that dual-antiplatelet therapy with thienopyridine and aspirin, for 30 (vs. 12) months after coronary stenting, had beneficial effects regardless of whether patients had acute myocardial infarction (MI) or less acute presentations ...
Ganeshan, Raj, Malm, Brian, Concato, John   +2 more
openaire   +2 more sources